Details for New Drug Application (NDA): 214341
✉ Email this page to a colleague
The generic ingredient in DEFERASIROX is deferasirox. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the deferasirox profile page.
Summary for 214341
Tradename: | DEFERASIROX |
Applicant: | Annora Pharma |
Ingredient: | deferasirox |
Patents: | 0 |
Suppliers and Packaging for NDA: 214341
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEFERASIROX | deferasirox | TABLET;ORAL | 214341 | ANDA | Camber Pharmaceuticals, Inc. | 31722-011 | 31722-011-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-011-30) |
DEFERASIROX | deferasirox | TABLET;ORAL | 214341 | ANDA | Camber Pharmaceuticals, Inc. | 31722-012 | 31722-012-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-012-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 90MG | ||||
Approval Date: | May 14, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 180MG | ||||
Approval Date: | May 14, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 360MG | ||||
Approval Date: | May 14, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription